Abstract:Besides the pathological hallmarks of β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs), increasing evidence suggests that neuroinflammation plays a significant role in AD pathogenesis. The complement pathway is a key regulator of innate immunity. Recent findings from our laboratory showed that the central complement component C3 is upregulated in astrocytes of AD patients and mouse models. Moreover, elevated astroglial C3 can modulate Aβ dynamics and pathology and reduce dendritic morphology and synaptic function through microglial and neuronal C3a receptor (C3aR), respectively. Giving the importance of the C3-C3aR axis in the CNS, we are interested in understanding whether the complement pathway also impacts the NFT pathology. We analyzed the expression patterns of complement pathway genes in AD, MCI and non-cognitive impaired brain samples obtained from the Religious Orders Study (ROS) and Rush Memory and Aging Project (MAP) cohorts and in the PS19 mouse model of tauopathy before or after the onset of NFT pathology. Next, we studied the functional effects of the C3-C3aR pathway on reactive gliosis and NFT pathology by genetically deleting C3aR or overexpressing neuronal C3aR in PS19 animals. Finally, we utilized RNA sequencing and reverse-phase proteomics (RPPA) to identify C3aR downstream signaling pathways that promote such effects. Analysis of RNA sequencing datasets from human brains revealed a strong upregulation of complement pathway genes that is highly correlated with Braak staging and cognitive decline. Prominent complement upregulation was also observed in PS19 mice in response to NFT pathology. AAV-driven neuronal overexpression of C3aR exacerbates tau/NFT pathology in PS19 animals. Conversely, knocking out C3aR in PS19 mice results in significant reduction of inflammation, phospho-tau levels and associated pathology and improved behavioral deficits of PS19 animals. Mechanistically, we identify the Jak-Stat3 pathway as a potent regulator of reactive gliosis and tau pathology in PS19 mice downstream of C3aR.

C3a Receptor Mediates Protection of Apolipoprotein E-deficient (apoe−/−) Mice from the Development of Atherosclerosis

Protective Role of C3aR (c3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.

Complement Component C3 Promotes Cerebral Ischemia/Reperfusion Injury Mediated by TLR2/NFκB Activation in Diabetic Mice.

Overexpression Of Complement Component C5a Accelerates The Development Of Atherosclerosis In Apoe-Knockout Mice

ApoE attenuates unresolvable inflammation by complex formation with activated C1q

Targeted Mouse Complement Inhibitor CR2-Crry Protects Against the Development of Atherosclerosis in Mice

Complement protein C1q modulates lipoprotein metabolism in macrophage foam cells

Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8+ T cell response

CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.

Role of C5a-C5aR axis in the development of atherosclerosis

Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease

THE ROLE OF COMPLEMENT C3 AND C3AR RECEPTOR IN TAU PATHOLOGY IN ALZHEIMER’S DISEASE

Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease

[O1–14–03]: THE ROLE OF COMPLEMENT C3 AND C3AR RECEPTOR IN TAU PATHOLOGY IN ALZHEIMER's DISEASE

Complement C3aR depletion reverses HIF-1α–induced metabolic impairment and enhances microglial response to Aβ pathology

The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.

Complement System and Pathogenesis of Alzheimer's Disease

Cytoprotective effects of C1s enzyme in macrophages in atherosclerosis mediated through the LRP5 and Wnt/β-catenin pathway

C/EBPβ/AEP signaling couples atherosclerosis to the pathogenesis of Alzheimer’s disease

Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia

Target Deletion of Complement Component 9 Attenuates Antibody-Mediated Hemolysis and Lipopolysaccharide (Lps)-Induced Acute Shock in Mice